Saturday, November 23, 2024
HomeTags24 Healthy Subjects

24 Healthy Subjects

Ascletis Announces Dosing of 24 Healthy Subjects of the First 3 Cohorts

Ascletis Pharma Inc. announces dosing of 24 healthy subjects of the first 3 cohorts in multiple-dose escalation Phase I clinical trial of oral RNA-dependent...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics